Document is current
Any future updates will be listed below
-
Authors
Lurgain, Jone G.
Peremiquel-Trillas, Paula
Ouaarab-Essadek, Hakima
Mellouki, Khadija
Malik-Hameed, Sumaira
Sarif, Andleed
Rangel-Sarmiento, Valentina
Bruni, Laia
Harling, Guy
Gilham, Clare
-
Funding
Funding for this research was provided by:
Economic and Social Research Council (ES-P000592/1)
CIBERESP (CB06/02/0073)
Secretariat for Universities and Research of the Department of Business and Knowledge of the Government of Catalonia (2021SGR01029)
- License Information
-
More Information
Article History
Received: 19 July 2024
Accepted: 8 September 2025
First Online: 20 November 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Research Ethics Committees of the London School of Hygiene and Tropical Medicine (protocol code 26186, approved on the 12th of July 2022), Bellvitge University Hospital (PR 140/22, approved on the 1st of July 2022) and Vall d’Hebron University Hospital (PR(AG)317/2022, approved on 29th of September 2022). Written informed consent was obtained from all subjects involved in the study to be interviewed and publish this paper.
: Not applicable.
: The Cancer Epidemiology Research Program, to which VRS, LB and PPT belong, has received support for research purposes from Vitro, Roche, Seegene, Hologic, Merck Sharp & Dohme, and Werfen, and for educational purposes from Merck Sharp & Dohme through e-oncologia. PPT has received a speaker’s honoraria from Werfen. The rest of co-authors declare no competing interests.
